19135, Philadelphia, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 19135, Philadelphia, Pennsylvania is 93 when comparing 34,000 ZIP Codes in the United States.

An estimate of 94.46 percent of the residents in 19135 has some form of health insurance. 55.95 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 47.19 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 19135 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 11,584 residents under the age of 18, there is an estimate of 512 pediatricians in a 20-mile radius of 19135. An estimate of 103 geriatricians or physicians who focus on the elderly who can serve the 3,379 residents over the age of 65 years.

In a 20-mile radius, there are 101,532 health care providers accessible to residents in 19135, Philadelphia, Pennsylvania.

## Prostate Cancer Score: A Philadelphia (19135) Perspective

Analyzing prostate cancer care within Philadelphia's 19135 ZIP code requires a multifaceted approach, considering both the availability of specialized medical expertise and the broader healthcare ecosystem supporting patient well-being. This analysis will attempt to provide a "Prostate Cancer Score" assessment, factoring in physician-to-patient ratios, standout practices, telemedicine utilization, and the accessibility of mental health resources, all within the context of primary care availability in the city.

The foundation of any prostate cancer care assessment rests on the availability of qualified specialists. Within 19135, the concentration of urologists, radiation oncologists, and medical oncologists is a critical data point. Calculating a physician-to-patient ratio involves estimating the population of 19135 and comparing it to the number of specialists practicing within or easily accessible to the area. This ratio provides a basic indicator of access; a lower ratio generally suggests better access to specialists. However, this is just the beginning.

Beyond sheer numbers, the quality of care is paramount. Identifying "standout practices" necessitates examining factors such as board certifications, experience, and patient outcomes. This involves researching practices known for their expertise in prostate cancer diagnosis and treatment. Are they utilizing the latest diagnostic tools like advanced imaging (MRI fusion biopsies) and genomic testing? Are they offering a range of treatment options, including minimally invasive surgical techniques (robotic-assisted prostatectomy), radiation therapy (IMRT, brachytherapy), and advanced systemic therapies (hormone therapy, chemotherapy, targeted therapies)? Practices with a demonstrated commitment to these advanced approaches would likely score higher.

Primary care availability is a crucial supporting factor. A robust primary care network is essential for early detection and ongoing management of prostate cancer. Primary care physicians (PCPs) play a vital role in screening, patient education, and coordinating care with specialists. The density of PCPs within and around 19135, along with their willingness to refer patients promptly to specialists, significantly impacts the overall score. The presence of Federally Qualified Health Centers (FQHCs) or other community health clinics, which often serve underserved populations, is also a positive indicator.

Telemedicine has emerged as a significant force in healthcare, particularly during and after the COVID-19 pandemic. Its adoption by specialists and PCPs in 19135 can enhance access to care, especially for follow-up appointments, medication management, and consultations. Practices that offer telemedicine options, including virtual consultations and remote monitoring, would likely receive a higher score, as they are demonstrating a commitment to patient convenience and accessibility.

The psychological and emotional impact of a prostate cancer diagnosis and treatment is substantial. Therefore, the availability of mental health resources is a critical component of a comprehensive care model. This includes access to therapists, counselors, and support groups specializing in oncology or men's health. The presence of these resources within the 19135 area or easily accessible through referrals is a significant factor in the overall score. Integration of mental health services into the cancer care pathway, such as offering on-site counseling or collaborating with mental health professionals, would further enhance the score.

Evaluating the overall "Prostate Cancer Score" requires synthesizing these factors. The presence of a high physician-to-patient ratio, combined with standout practices utilizing advanced technologies and treatment options, would be a positive indicator. Strong primary care availability, coupled with widespread telemedicine adoption, would further boost the score. Finally, the availability of robust mental health resources would complete the picture of a comprehensive and patient-centered care environment.

It is important to acknowledge the limitations of this analysis. Publicly available data on physician-to-patient ratios and practice performance can be incomplete. Accessing detailed information on specific practices and their patient outcomes may be challenging. Furthermore, the subjective nature of patient experience and satisfaction is difficult to quantify. Therefore, this "Prostate Cancer Score" should be considered an estimate, providing a general overview of the care landscape within 19135.

To improve the accuracy and detail of this analysis, it would be beneficial to incorporate data from various sources. This includes publicly available information from the Pennsylvania Department of Health, the Centers for Medicare & Medicaid Services (CMS), and professional organizations like the American Urological Association. Patient reviews and satisfaction surveys, if available, could also provide valuable insights.

In conclusion, assessing the prostate cancer care landscape in 19135 requires a holistic approach, considering not just the availability of specialists but also the supporting healthcare infrastructure. This includes primary care, telemedicine, and mental health resources. By evaluating these factors, a more comprehensive understanding of the quality and accessibility of care can be achieved.

To visualize this data and explore the healthcare landscape of Philadelphia, including physician locations, primary care availability, and mental health resources, we encourage you to explore CartoChrome maps. CartoChrome can transform complex data into interactive and insightful visualizations, enabling you to gain a deeper understanding of the healthcare environment in your area.